Establishment of an ophthalmology and ENT specialist hospital
Related departments from Zhongshan and Huashan hospitals merged, creating a foundation for the joint development of the two disciplines.
First nationally for ENT reputation and among the top three in ophthalmology, bringing original techniques to the world.
In the 2023 Fudan National Specialty Reputation Rankings, ENT ranked first and ophthalmology third. Since its founding in 1952, the hospital has developed both as national key disciplines, with National Health Commission key laboratories in auditory medicine and myopia. From refractive surgical instruments recognized by a National Technological Invention Award to hereditary deafness gene therapy research published in The Lancet, its standing is supported by original contributions.
Founded by pioneers of Chinese ophthalmology and otolaryngology, the hospital developed distinct technical traditions in refractive surgery, glaucoma prevention, hearing reconstruction and endoscopic nasal skull-base surgery. A National Technological Invention Award, national 973 hearing research and hereditary deafness gene therapy provide concrete examples of their continuing progress.
Discover this specialist hospital, founded in 1952, through its national specialty reputation, national research platforms and original medical contributions.
2023 Fudan rankings · Published in November 2024
2023 national specialty reputation
2023 national specialty reputation
Fudan's specialty introduction
These figures reflect national specialty reputation for the stated year, rather than overall hospital or treatment outcome rankings.
Both ophthalmology and ENT are national key disciplines and national key clinical specialties, forming dedicated systems for vision and hearing disorders.
The Key Laboratory of Hearing Medicine and the Key Laboratory of Myopia connect research in auditory injury, visual function and myopia prevention with clinical care.
A microkeratome system for refractive surgery received the 2007 National Technological Invention Second Prize. In 2024, a hospital-led single-arm clinical study of gene therapy for hereditary deafness was published in The Lancet.
Related departments from Zhongshan and Huashan hospitals merged, creating a foundation for the joint development of the two disciplines.
The key technologies and applications of a microkeratome system, developed under Chu Renyuan's guidance with Zhou Xingtao and colleagues, received a National Technological Invention Second Prize.
A 2024 Fudan retrospective records that Zhou Xingtao performed China's first small-incision lenticule extraction procedure in May 2010, followed by research on continuous lenticule dissection and lenticule reuse.
A study of OTOF-related hereditary deafness led by Shu Yilai, with Li Huawei and other collaborators, was published, advancing clinical exploration of inner-ear gene delivery.
Explore Eye & ENT Hospital's contributions in each field, from specialty standing to notable achievements, and the conditions this expertise supports.
2023 Fudan National Specialty Reputation Rankings · Ophthalmology
A long tradition in modern Chinese ophthalmology has developed into original refractive surgery techniques and comprehensive glaucoma management. The discipline combines a national key platform with documented device innovations and contributions to blindness prevention.
Chu Renyuan guided Zhou Xingtao and colleagues in device development. The award-winning work connected key myopia surgery technologies with clinical applications.
Zhou Xingtao performed small-incision lenticule extraction and subsequently developed SMILE-CCL continuous lenticule dissection and research on corneal lenticule transplantation.
Sun Xinghuai founded the Shanghai Glaucoma Club, connecting disease education, awareness of long-term follow-up and specialist care. In 2016 he received the Outstanding Science Communication Figure award under the Shanghai Science Education Innovation Awards.
Fudan's introduction lists both national designations for ophthalmology.
Connecting basic research, clinical techniques and professional training in myopia and vision-related problems.
The refractive surgery team addresses myopia, astigmatism and complex corneal problems. The glaucoma and optic nerve teams focus on preserving visual function and long-term management. These areas involve different examinations, treatments and follow-up needs.
2023 Fudan National Specialty Reputation Rankings · ENT
The nationally first-ranked ENT department connects research into hearing mechanisms, otologic microsurgery and endoscopic rhinology and skull-base techniques. Its representative work appears in international medical journals and in surgical consensus statements and technical frameworks.
The hospital led a single-arm clinical study of OTOF-related hereditary deafness, directed by Shu Yilai, with Li Huawei among the co-corresponding authors. This achievement is clinical gene therapy research.
Yu Hongmeng proposed a new classification of endoscopic surgery for nasopharyngeal carcinoma, led expert consensus on surgical treatment, and advanced reconstruction of nasopharyngeal and skull-base defects.
Supporting research into auditory injury mechanisms, repair and hearing reconstruction.
The innovation unit for endoscopic surgical treatment of nasal and skull-base tumors studies anatomy, technical innovation and digital diagnosis and treatment.
The hearing team's areas include cochlear implantation, otitis media, otosclerosis and facial nerve surgery. The rhinology and skull-base team treats nasal, sinus, nasopharyngeal and skull-base tumors and related reconstruction. Gene therapy for hereditary deafness requires separate assessment within the relevant research program.
Discover the specialists' contributions and the conditions and treatments they focus on.
Showing 4 representative specialists
Ophthalmology
Chief physician · Professor · Doctoral supervisor
Contributor to the 2007 National Technological Invention Second Prize · National Most Beautiful Doctor recognition, 2022
Ask about this doctorHis expertise centers on myopia prevention, refractive correction and complex corneal disease, connecting surgical instrument development, lenticule extraction techniques and reuse of corneal tissue.
He performed China's first procedure in May 2010 and subsequently developed techniques including SMILE-CCL continuous lenticule dissection.
Under Chu Renyuan's guidance, he and his team completed research into key technologies and applications of a microkeratome system for myopia surgery.
The receiving doctor, campus and appointment time depend on hospital arrangements.
Ophthalmology
Chief physician · Professor
Chinese Ophthalmology Outstanding Achievement Award, 2014
Ask about this doctorHe has long treated glaucoma, optic nerve disorders and low vision, combining research on disease mechanisms with long-term management involving both doctors and patients.
He received the highest academic award established by the Chinese Ophthalmological Society, recognizing his contributions to ophthalmic research, blindness prevention and professional training.
He established a disease education platform bringing specialists and patients together to support long-term glaucoma management. In 2016 he received the Outstanding Science Communication Figure award under the Shanghai Science Education Innovation Awards.
The receiving doctor, campus and appointment time depend on hospital arrangements.
Otolaryngology–head and neck surgery
Chief physician · Professor
Chief scientist of a national 973 project · Recipient of the National Science Fund for Distinguished Young Scholars
Ask about this doctorHis research focuses on auditory injury and repair, while his clinical work covers cochlear implantation, otologic microsurgery and facial nerve disorders. He advances basic inner-ear research into clinical studies of hereditary deafness.
He led research on mechanisms and interventions for sensorineural hearing loss, focusing on auditory injury and repair.
He was a co-corresponding author of the hospital-led single-arm OTOF gene therapy trial, collaborating with Shu Yilai and others.
The receiving doctor, campus and appointment time depend on hospital arrangements.
Otolaryngology–head and neck surgery
Chief physician · Professor · Doctoral supervisor
Shanghai Craftsman recognition, 2023 · Head of a Chinese Academy of Medical Sciences innovation unit
Ask about this doctorHis work in nasopharyngeal and nasal skull-base tumors combines anatomical research, endoscopic resection, vascular protection and tissue repair into a surgical framework for complex lesions.
He led expert consensus on surgical treatment of nasopharyngeal carcinoma and proposed a new endoscopic classification, advancing technical standards for complex operations.
He innovated the use of temporalis and submental flaps and organized medical-engineering teams to develop endoscopic screening algorithms and multimodal imaging models for nasopharyngeal carcinoma.
The receiving doctor, campus and appointment time depend on hospital arrangements.
These profiles describe professional expertise and notable experience. The doctor, campus and appointment time are confirmed when arranging care.
Tell eastmedgo about the specialty, doctor or care question that matters to you, through WhatsApp or email.
Initial service inquiries are free. Medical assessments and treatment recommendations are provided by the receiving hospital and doctors.